Found: 6
Select item for more details and to access through your institution.
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1170012
- By:
- Publication type:
- Article
Innate PD-L1 limits T cell–mediated adipose tissue inflammation and ameliorates diet-induced obesity.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 635, p. 1, doi. 10.1126/scitranslmed.abj6879
- By:
- Publication type:
- Article
Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02509-8
- By:
- Publication type:
- Article
Interleukin-26 activates macrophages and facilitates killing of Mycobacterium tuberculosis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-73989-y
- By:
- Publication type:
- Article
Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events.
- Published in:
- Allergy, 2019, v. 74, n. 12, p. 2437, doi. 10.1111/all.13972
- By:
- Publication type:
- Article
Discovery and multi-parametric optimization of a high-affinity antibody against interleukin-25 with neutralizing activity in a mouse model of skin inflammation.
- Published in:
- Antibody Therapeutics, 2022, v. 5, n. 4, p. 258, doi. 10.1093/abt/tbac022
- By:
- Publication type:
- Article